A New Study: RESPeRATE may prevent hypertension
Written by Eli Ben-YehudaOn September 5, 2019
A new peer-reviewed clinical study, just published in the Journal of Applied Physiology by researchers from Quebec’s McGill University, determined that RESPeRATE lowers blood pressure within one session, even in young healthy individuals. It also found that RESPeRATE effectively reduces muscle sympathetic nerve activity and blood pressure in both genders, despite having lower baseline values in women.
The study concludes that RESPeRATE may be an effective preventative therapy against the development of hypertension.
The purpose of this study was to determine whether there is an effect of sex on BP and associated autonomic responses to an acute 15-min session with the RESPeRATE device among young healthy individuals.
Based on the 2017 AHA guidelines for blood pressure (BP) management, 46% of adults in the United States have hypertension . These numbers are equally concerning for women as for men— 43% of adult women are hypertensive and that approximately 16% of adults with high BP have drug-resistant hypertension the evaluation and establishment of non-pharmacological treatments is clearly a public health priority.
Given that even slightly elevated BP is associated with increased risk of adverse cardiovascular events slightly elevated BP is associated with increased risk of adverse cardiovascular events slightly elevated BP is associated with increased risk of adverse cardiovascular events.
As a result, in 2013 the American Heart Association (AHA) issued a Class IIA recommendation RESPeRATE as an effective treatment to lower BP in hypertensive individuals.
Contrary to the studies hypothesis, the researchers found that BP responses to RESPeRATE were not sex-dependent in the population of young, normotensive individuals. Rather, induced similar decreases in BP in individuals of both sexes.
Their finding that RESPeRATE acutely reduces systolic BP is in alignment with past research. However, they are the first to demonstrate that these trends are also observed in young female individuals, despite having lower baseline BP compared to males.
The study also found that in both female and male individuals, RESPeRATE reduced muscle sympathetic nerve activity and sensitized the cardiovagal efferent arm of the baroreflex (in response to increasing SBP only).
The researches say this data provided compelling preliminary support for the use of RESPeRATE an anti-hypertensive tool for use in young female individuals, a clinically-relevant finding.
The researchers concluded that given their findings RESPeRATE may be an affective preventative therapy against the development of hypertension.
See for study abstract and full text article here
To learn more about what is RESPeRATE and how does it work, here click here.Tags:
How to Lower Blood Pressure Fast & Naturally.
RESPeRATE is the only non-drug, FDA-Cleared device for lowering blood pressure naturally. It is clinically proven, doctor recommended and has no side effects.
RESPeRATE lowers blood pressure by relaxing constricted blood vessels which cause high blood pressure. RESPeRATE does so by harnessing the therapeutic power of slow-paced breathing with prolonged exhalation in a way that is virtually impossible to achieve on your own. All you have to do is breathe along with RESPeRATE’s guiding tones.
- Clinically proven
- Over 250,000 Customers
- FDA Cleared
- No Side Effects
Get 10 Tips to Lower Blood Pressure.
You will also receive our bi-weekly RESPeRATE Journal.
By using this form you agree with the storage and handling of your data by this website.